Related Articles
Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study
Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
COCH predicts survival and adjuvant TACE response in patients with HCC
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)
Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma